ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 046,74
0,25%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Neurocrine Biosciences Inc (NBIX)

  7. Neurocrine Biosciences Inc (NBIX) Actualités

NBIX Neurocrine Biosciences Inc

140,71
0,88 (0,63%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Neurocrine Biosciences Inc NBIX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,88 0,63% 140,71 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
140,90 139,23 141,88 140,71 139,83
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
03/5/202419:15PRNUSNeurocrine Biosciences Presented CAHtalyst™ Pediatric Study..
01/5/202413:00PRNUSNeurocrine Biosciences Reports First Quarter 2024 Financial..
30/4/202423:12PRNUSNeurocrine Biosciences Announces U.S. FDA Approval of..
24/4/202414:30PRNUSNeurocrine Biosciences Launches WHAT THE C@H?! Educational..
23/4/202413:00PRNUSNeurocrine Biosciences Reports Positive Phase 2 Data for..
16/4/202422:01GLOBESentia Medical Sciences and Neurocrine Biosciences Extend..
10/4/202422:01PRNUSNeurocrine Biosciences Announces Conference Call and Webcast..
03/4/202414:30PRNUSNeurocrine Biosciences Announces First-Patient Dosed in..
28/3/202413:30PRNUSNeurocrine Biosciences Announces Initiation of Phase 1..
11/3/202421:01PRNUSNeurocrine Biosciences to Participate at Virtual Investor..
08/3/202422:22EDGAR2Form 144 - Report of proposed sale of securities
08/3/202422:22EDGAR2Form 144 - Report of proposed sale of securities
01/3/202401:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202400:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202400:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:29EDGAR2Form 144 - Report of proposed sale of securities
27/2/202422:01PRNUSNeurocrine Biosciences to Participate at Investor..
22/2/202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202422:33EDGAR2Form 144 - Report of proposed sale of securities
15/2/202423:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202423:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202423:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202423:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202423:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202423:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202423:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202423:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202423:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202422:34EDGAR2Form 144 - Report of proposed sale of securities
13/2/202422:34EDGAR2Form 144 - Report of proposed sale of securities
13/2/202422:34EDGAR2Form 144 - Report of proposed sale of securities
13/2/202422:33EDGAR2Form 144 - Report of proposed sale of securities
13/2/202422:20EDGAR2Form 144 - Report of proposed sale of securities
13/2/202422:20EDGAR2Form 144 - Report of proposed sale of securities
13/2/202422:19EDGAR2Form 144 - Report of proposed sale of securities
13/2/202422:19EDGAR2Form 144 - Report of proposed sale of securities
13/2/202422:18EDGAR2Form 144 - Report of proposed sale of securities
13/2/202422:17EDGAR2Form 144 - Report of proposed sale of securities
13/2/202422:17EDGAR2Form 144 - Report of proposed sale of securities
09/2/202423:29EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
09/2/202401:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202401:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202401:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202401:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202401:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202401:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202401:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
NBIX
Neurocrine Biosciences
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés